Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11NO2 |
Molecular Weight | 153.1784 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CN)=CC=C1O
InChI
InChIKey=WRPWWVNUCXQDQV-UHFFFAOYSA-N
InChI=1S/C8H11NO2/c1-11-8-4-6(5-9)2-3-7(8)10/h2-4,10H,5,9H2,1H3
Molecular Formula | C8H11NO2 |
Molecular Weight | 153.1784 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Enzymatic synthesis of vanillin. | 2001 Jun |
|
Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen. | 2001 Jun |
|
Methyl jasmonate modulated biotransformation of phenylpropanoids to vanillin related metabolites using Capsicum frutescens root cultures. | 2005 Feb |
|
Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells. | 2006 Feb 23 |
|
In vitro hepatic and skin metabolism of capsaicin. | 2008 Apr |
|
Influence of "remote" intramolecular hydrogen bonds on the stabilities of phenoxyl radicals and benzyl cations. | 2010 Jul 2 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:57:36 GMT 2023
by
admin
on
Fri Dec 15 18:57:36 GMT 2023
|
Record UNII |
1WEZ91E3Z0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1WEZ91E3Z0
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
1196-92-5
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
149596
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
Vanillylamine
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
156075
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
46958
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
70966
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
1WEZ91E3Z0
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
C003754
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY | |||
|
DTXSID90152522
Created by
admin on Fri Dec 15 18:57:36 GMT 2023 , Edited by admin on Fri Dec 15 18:57:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
In incubation medium and skin vanillylamine ranged from 4.37 to 19.8% of the radioactivity in each sample at all concentrations.
SKIN
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |